Camphene

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Camphene is an excipient in medications for flavouring.

Generic Name
Camphene
DrugBank Accession Number
DB15917
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 136.238
Monoisotopic: 136.125200515
Chemical Formula
C10H16
Synonyms
  • DL-Camphene
External IDs
  • 201-234-8
  • FEMA NO. 2229
  • NSC-4165

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
ROWACHOL CAPSULESCamphene (5 mg) + Borneol (5 mg) + Eucalyptol (2 mg) + Levomenthol (32 mg) + Menthone (6 mg) + Olive oil (33 mg) + alpha-Pinene (17 mg)CapsuleOralDCH AURIGA (MALAYSIA) SDN. BHD.2020-09-08Not applicableMalaysia flag
URINEX (Enteric-Coated) Soft Gelatin CapsulesCamphene (15 mg) + Anethole (4 mg) + Borneol (10 mg) + Eucalyptol (3 mg) + Fenchone (4 mg) + alpha-Pinene (24.8 mg) + beta-Pinene (6.2 mg)Capsule, gelatin coatedOralPharco Health Sdn. Bhd2020-09-08Not applicableMalaysia flag
โรวาคอลCamphene (5 mg) + Borneol (5 mg) + Eucalyptol (2 mg) + Levomenthol (32 mg) + Menthone (6 mg) + alpha-Pinene (13.6 mg) + beta-Pinene (3.4 mg)Capsuleบริษัท ดีซีเอช ออริกา (ประเทศไทย) จำกัด1986-09-25Not applicableThailand flag
โรวาทีเน็กCamphene (15 mg) + Anethole (4 mg) + Borneol (10 mg) + Eucalyptol (3 mg) + Fenchone (4 mg) + alpha-Pinene (24.8 mg) + beta-Pinene (6.2 mg)Capsuleบริษัท ดีซีเอช ออริกา (ประเทศไทย) จำกัด1987-05-22Not applicableThailand flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
G3VG94Z26E
CAS number
79-92-5
InChI Key
CRPUJAZIXJMDBK-UHFFFAOYSA-N
InChI
InChI=1S/C10H16/c1-7-8-4-5-9(6-8)10(7,2)3/h8-9H,1,4-6H2,2-3H3
IUPAC Name
2,2-dimethyl-3-methylidenebicyclo[2.2.1]heptane
SMILES
CC1(C)C2CCC(C2)C1=C

References

General References
  1. FDA Thailand: Rowatinex (Anethole, Borneol, Camphene, Eucalyptol, Fenchone, Alpha-Pinene, Beta-Pinene) Capsule [Link]
Human Metabolome Database
HMDB0059839
KEGG Compound
C06076
ChemSpider
6364
RxNav
2395761
ChEBI
3830
ChEMBL
CHEMBL2268550
Wikipedia
Camphene

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
CapsuleOral
Capsule, gelatin coatedOral
Capsule
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0621 mg/mLALOGPS
logP4.56ALOGPS
logP2.86Chemaxon
logS-3.3ALOGPS
Physiological Charge0Chemaxon
Hydrogen Acceptor Count0Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area0 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity43.65 m3·mol-1Chemaxon
Polarizability16.95 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-2900000000-316f2dcc6d1064b25ba7
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-000i-0900000000-add3ae6c1eaa614db1cf
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-9800000000-ae3259c0f4abee321bae
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-000i-0900000000-01fcceb18f45df5e2f47
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-00kr-0900000000-37071f03f233b01e8b67
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4j-9800000000-24258851eefb50b5f905
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-128.78436
predicted
DeepCCS 1.0 (2019)
[M+H]+132.5238
predicted
DeepCCS 1.0 (2019)
[M+Na]+141.48235
predicted
DeepCCS 1.0 (2019)

Drug created at November 23, 2020 14:33 / Updated at May 07, 2021 21:08